Category: Blood Diseases
Blood Diseases market research reports by IMARC Services Pvt. Ltd.
-
Prenatal and Newborn Genetic Testing Market Report by Product Type (Consumables, Instruments), Screening (Non-invasive Prenatal Testing, Chorionic Villus Sampling, Amniocentesis, Maternal Serum Screening), Disease (Downs Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia), End User (Hospital, Maternity and Specialty Clinics, Diagnostic Centers), and Region 2025-2033
The global prenatal and newborn genetic testing market size reached USD 6.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 17.3 Billion by 2033, exhibiting a growth rate (CAGR) of 11.04% during 2025-2033. The market share is experiencing steady growth driven by the gro ... Read More
-
China Genetic Testing Market Report by Test Type (Prenatal Testing, Carrier Testing, New Born Testing, Predictive/Presymptomatic Testing, Diagnostic Testing, and Others), Disease (Cancer, Down Syndrome, Thalassemia, and Others), Technology (Biochemical, Molecular, Cytogenetic), Service Provider (Hospital Based Laboratories, Independent Laboratories, Specialty Clinics), Testing Sample (Blood, Saliva, Hair, and Others) 2025-2033
The China genetic testing market size reached USD 4.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 16.4 Billion by 2033, exhibiting a growth rate (CAGR) of 13.68% during 2025-2033. Genetic testing, also known as DNA testing, provides the determination of bloodlines a ... Read More
-
Biosimilar Market Report by Molecule (Infliximab, Insulin Glargine, Epoetin Alfa, Etanercept, Filgrastim, Somatropin, Rituximab, Follitropin Alfa, Adalimumab, Pegfilgrastim, Trastuzumab, Bevacizumab, and Others), Indication (Auto-Immune Diseases, Blood Disorders, Diabetes, Oncology, Growth Deficiency, Female Infertility, and Others), Manufacturing Type (In-house Manufacturing, Contract Manufacturing), and Region 2025-2033
Biosimilar Market Report by Molecule (Infliximab, Insulin Glargine, Epoetin Alfa, Etanercept, Filgrastim, Somatropin, Rituximab, Follitropin Alfa, Adalimumab, Pegfilgrastim, Trastuzumab, Bevacizumab, and Others), Indication (Auto-Immune Diseases, Blood Disorders, Diabetes, Oncology, Growth Deficienc ... Read More
-
PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033
PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal D ... Read More
-
Hemophilia Market Report by Type (Hemophilia A, Hemophilia B, Hemophilia C, and Others), Treatment (On-Demand, Prophylaxis), Therapy (Replacement Therapy, ITI Therapy, Gene Therapy), and Region 2024-2032
Hemophilia Market Report by Type (Hemophilia A, Hemophilia B, Hemophilia C, and Others), Treatment (On-Demand, Prophylaxis), Therapy (Replacement Therapy, ITI Therapy, Gene Therapy), and Region 2024-2032 The global hemophilia market size reached US$ 13.0 Billion in 2023. Looking forward, IMARC Group ... Read More
-
Hemophilia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Hemophilia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 The global hemophilia market size reached US$ 11.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 22.3 Billion by 2028, exhibiting a growth rate (CAGR) of 11.35% during 2 ... Read More
-
Bleeding Disorders Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Bleeding Disorders Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 Market Overview: The global bleeding disorders treatment market size reached US$ 14.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 20.3 Billion by 202 ... Read More
Research Assistance
